Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Detection of plasmid DNA vectors following gene transfer to the murine airways

Abstract

Non-viral gene therapy is being considered as a treatment for cystic fibrosis. In clinical studies and in studies using the mouse airways as a model, current formulations result in only transient transgene expression. A number of reasons for this have been proposed including the loss of plasmid DNA from cells. The aim of these studies was to investigate why transgene expression from non-viral vectors is transient in the mouse lung. Plasmid DNA encoding the luciferase reporter gene was complexed with the cationic lipid GL67 and delivered to the mouse airways. The persistence of plasmid DNA in the mouse lungs was investigated using quantitative PCR and Southern hybridization. Results showed that intact plasmid DNA persisted in the mouse lung in the absence of any detectable luciferase activity. The de novo methylation of plasmid DNA in vivo was investigated as a potential cause of this transient gene expression but results suggested that plasmid DNA does not become de novo methylated in the mouse lung. Therefore processes other than the loss of plasmid DNA from the lung or the de novo methylation of plasmid DNA vectors must be responsible for the transient transgene expression.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Gill DR, Davies LA, Pringle IA, Hyde SC . The development of gene therapy for diseases of the lung. Cell Mol Life Sci 2004; 61: 355–368.

    Article  CAS  PubMed  Google Scholar 

  2. Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066–1073.

    Article  CAS  PubMed  Google Scholar 

  3. Rommens JM et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059–1065.

    Article  CAS  PubMed  Google Scholar 

  4. Kerem B et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073–1080.

    Article  CAS  PubMed  Google Scholar 

  5. Bear CE et al. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 1992; 68: 809–818.

    Article  CAS  PubMed  Google Scholar 

  6. Hyde SC et al. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy. Nature 1993; 362: 250–255.

    Article  CAS  PubMed  Google Scholar 

  7. Alton EW et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat Genet 1993; 5: 135–142.

    Article  CAS  PubMed  Google Scholar 

  8. Gill DR et al. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 199–209.

    Article  CAS  PubMed  Google Scholar 

  9. Hyde SC et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 2000; 7: 1156–1165.

    Article  CAS  PubMed  Google Scholar 

  10. Alton EW et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 1999; 353: 947–954.

    Article  CAS  PubMed  Google Scholar 

  11. Porteous DJ et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 210–218.

    Article  CAS  PubMed  Google Scholar 

  12. Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum Gene Ther 1996; 7: 1701–1717.

    Article  CAS  PubMed  Google Scholar 

  13. Rose AC et al. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways. Gene Therapy 2002; 9: 1312–1320.

    Article  CAS  PubMed  Google Scholar 

  14. Jiang C et al. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum Gene Ther 1998; 9: 1531–1542.

    Article  CAS  PubMed  Google Scholar 

  15. Jaffe A et al. Cationic lipid-mediated gene transfer to the growing murine and human airway. Gene Therapy 2000; 7: 273–278.

    Article  CAS  PubMed  Google Scholar 

  16. Zabner J . Cationic lipids used in gene transfer. Adv Drug Delivery Rev 1997; 27: 17–28.

    Article  CAS  Google Scholar 

  17. Gill DR et al. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1 alpha promoter. Gene Therapy 2001; 8: 1539–1546.

    Article  CAS  PubMed  Google Scholar 

  18. Yew NS et al. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter. Mol Ther 2001; 4: 75–82.

    Article  CAS  PubMed  Google Scholar 

  19. Pieper U et al. The GTP-dependent restriction enzyme McrBC from Escherichia coli forms high-molecular mass complexes with DNA and produces a cleavage pattern with a characteristic 10-base pair repeat. Biochemistry 2002; 41: 5245–5254.

    Article  CAS  PubMed  Google Scholar 

  20. Stewart FJ, Raleigh EA . Dependence of McrBC cleavage on distance between recognition elements. Biol Chem 1998; 379: 611–616.

    CAS  PubMed  Google Scholar 

  21. Ferrari S, Geddes DM, Alton EW . Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Delivery Rev 2002; 54: 1373–1393.

    Article  CAS  Google Scholar 

  22. Niven R et al. Biodistribution of radiolabeled lipid–DNA complexes and DNA in mice. J Pharm Sci 1998; 87: 1292–1299.

    Article  CAS  PubMed  Google Scholar 

  23. Houk BE, Hochhaus G, Hughes JA . Kinetic modeling of plasmid DNA degradation in rat plasma. AAPS Pharm Sci 1999; 1: E9.

    Article  CAS  Google Scholar 

  24. Rozenberg-Arska M et al. Degradation of Escherichia coli chromosomal and plasmid DNA in serum. J Gen Microbiol 1984; 130 (Part 1): 217–222.

    CAS  PubMed  Google Scholar 

  25. Crook K, McLachlan G, Stevenson BJ, Porteous DJ . Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Therapy 1996; 3: 834–839.

    CAS  PubMed  Google Scholar 

  26. Chen ZY et al. Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol Ther 2001; 3: 403–410.

    Article  CAS  PubMed  Google Scholar 

  27. Siegfried Z et al. DNA methylation represses transcription in vivo. Nat Genet 1999; 22: 203–206.

    Article  CAS  PubMed  Google Scholar 

  28. Jahner D, Jaenisch R . Chromosomal position and specific demethylation in enhancer sequences of germ line-transmitted retroviral genomes during mouse development. Mol Cell Biol 1985; 5: 2212–2220.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Kuriyama S et al. Expression of a retrovirally transduced gene under control of an internal housekeeping gene promoter does not persist due to methylation and is restored partially by 5-azacytidine treatment. Gene Therapy 1998; 5: 1299–1305.

    Article  CAS  PubMed  Google Scholar 

  30. Robertson KD et al. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999; 27: 2291–2298.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Hsieh CL . Evidence that protein binding specifies sites of DNA demethylation. Mol Cell Biol 1999; 19: 46–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hsieh CL . Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol 1994; 14: 5487–5494.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Dupont JM, Tost J, Jammes H, Gut IG . De novo quantitative bisulfite sequencing using the pyrosequencing technology. Anal Biochem 2004; 333: 119–127.

    Article  CAS  PubMed  Google Scholar 

  34. Thomassin H, Oakeley EJ, Grange T . Identification of 5-methylcytosine in complex genomes. Methods 1999; 19: 465–475.

    Article  CAS  PubMed  Google Scholar 

  35. Inoshima Y, Morooka A, Murakami K, Sentsui H . Simple preparation of parapoxvirus genome DNA for endonuclease analysis. Microbiol Immunol 2000; 44: 69–72.

    Article  CAS  PubMed  Google Scholar 

  36. Kim SJ, Cheung S, Hellerstein MK . Isolation of nuclei from label-retaining cells and measurement of their turnover rates in rat colon. Am J Physiol Cell Physiol 2004; 286: C1464–C1473.

    Article  CAS  PubMed  Google Scholar 

  37. Storek MJ, Ernst A, Verdine GL . High-resolution footprinting of sequence-specific protein-DNA contacts. Nat Biotechnol 2002; 20: 183–186.

    Article  CAS  PubMed  Google Scholar 

  38. Loser P, Jennings GS, Strauss M, Sandig V . Reactivation of the previously silenced cytomegalovirus major immediate–early promoter in the mouse liver: involvement of NFkappaB. J Virol 1998; 72: 180–190.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Armentano D et al. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J Virol 1997; 71: 2408–2416.

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Paillard F . Promoter attenuation in gene therapy: causes and remedies. Hum Gene Ther 1997; 8: 2009–2010.

    CAS  PubMed  Google Scholar 

  41. Sung RS, Qin L, Bromberg JS . TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol Ther 2001; 3: 757–767.

    Article  CAS  PubMed  Google Scholar 

  42. Qin L et al. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther 1997; 8: 2019–2029.

    Article  CAS  PubMed  Google Scholar 

  43. Freimark BD et al. Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J Immunol 1998; 160: 4580–4586.

    CAS  PubMed  Google Scholar 

  44. Yew NS et al. CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo. Mol Ther 2002; 5: 731–738.

    Article  CAS  PubMed  Google Scholar 

  45. Brondyk WH, Groskreutz DJ . pCI and pSI mammalian expression vectors. Promega Notes 1994; 49: 7–11.

    Google Scholar 

  46. Rose AC . Studies on the expression of the murine CFTR gene: implications for gene therapy. Nuffield Department of Clinical Laboratory Sciences, Oriel College, University of Oxford, 2001.

  47. Southern EM . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503–517.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was funded by the Medical Research Council (UK) and the UK Cystic Fibrosis Trust.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pringle, I., Raman, S., Sharp, W. et al. Detection of plasmid DNA vectors following gene transfer to the murine airways. Gene Ther 12, 1206–1214 (2005). https://doi.org/10.1038/sj.gt.3302518

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302518

Keywords

This article is cited by

Search

Quick links